Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 17/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.57 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17611226 | 0.90 | AOC3 (0.79) | AOC3KCNH2 | |
| SCHEMBL17611154 | 0.88 | AOC3 (0.79) | AOC3KCNH2 | |
| SCHEMBL17611219 | 0.81 | AOC3 (0.79) | AOC3KCNH2 | |
| SCHEMBL19714877 | 0.81 | AOC3 (0.77) | AOC3KCNH2 | |
| SCHEMBL16052876 | 0.80 | KCNH2 (0.86) | AOC3KCNH2 | |
| SCHEMBL16048253 | 0.79 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL30026855 | 0.79 | AOC3 (1.00) | AOC3KCNH2 | |
| SCHEMBL16052748 | 0.78 | AOC3 (0.85) | AOC3KCNH2 | |
| SCHEMBL17075523 | 0.75 | AOC3 (1.00) | AOC3 | |
| SCHEMBL17624697 | 0.74 | AOC3 (0.67) | AOC3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362218-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN, LLC | 2017-12-21 | — | — | US | disclosed |
| US-20170362218-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | PROXIMAGEN, LLC | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362218-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVED SSAO INHIBITORS | SSB, PNPO, SSBP1 | AOC3 24/4885KCNH2 2665/4885CYP11B2 894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.